RLBFX
Price
$40.49
Change
+$0.07 (+0.17%)
Updated
Jul 31 closing price
Net Assets
288.09B
WFAIX
Price
$40.08
Change
+$0.14 (+0.35%)
Updated
Jul 31 closing price
Net Assets
1.2B
Interact to see
Advertisement

RLBFX vs WFAIX

RLBFX vs WFAIX Comparison Chart in %
View a ticker or compare two or three
VS
RLBFX vs. WFAIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLBFX is a Buy and WFAIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBFX has more cash in the bank: 288B vs. WFAIX (1.2B). RLBFX pays higher dividends than WFAIX: RLBFX (2.05) vs WFAIX (0.97). RLBFX was incepted earlier than WFAIX: RLBFX (24 years) vs WFAIX (27 years). WFAIX (1.01) is less costly to investors than RLBFX (0.30). RLBFX is a more actively managed with annual turnover of: 50.00 vs. WFAIX (19.00). RLBFX has a lower initial minimum investment than WFAIX: RLBFX (250) vs WFAIX (1000000). RLBFX annual gain was more profitable for investors over the last year : 11.63 vs. WFAIX (0.60). RLBFX return over 5 years is better than : 34.02 vs. WFAIX (-6.07).
RLBFXWFAIXRLBFX / WFAIX
Total Expense Ratio0.300.9033%
Annual Report Gross Expense Ratio0.301.0130%
Fund Existence24 years27 years-
Gain YTD8.5715.584153%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets288B1.2B24,060%
Annual Yield % from dividends2.050.97212%
Returns for 1 year11.630.601,922%
Returns for 3 years39.877.01569%
Returns for 5 years34.02-6.07-561%
Returns for 10 years86.2445.84188%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JSGRX29.320.33
+1.14%
JHancock U.S. Growth R2
MNHWX27.000.22
+0.82%
Manning & Napier Pro-Blend Max Term W
SCICX71.590.30
+0.42%
Columbia Seligman Tech & Info C
GSURX66.880.18
+0.27%
Goldman Sachs US Equity Insights R
PZVMX13.81-0.15
-1.07%
Pzena Mid Cap Value Investor